rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
In this study, a novel mutation in APP gene, Val669Leu ("Seoul APP"), was reported in a Korean female patient with Alzheimer's disease.
|
31623876 |
2019 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Dermal fibroblasts were obtained from a 55 year old male Сaucasian familial Alzheimer's disease (AD) patient carrying heterozygous V717I mutation in the APP gene.
|
30851551 |
2019 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
In this study, we utilized two animal models of AD to examine and characterize the AD-associated pathology: the Tg2576 Swedish APP (KM670/671NL) and TgCRND8 Swedish plus Indiana APP (KM670/671NL + V717F) lines.
|
30189875 |
2018 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
|
28885485 |
2017 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
To probe for a function of ABCA7 in vivo, we crossed Abca7(-/-) mice with J20 mice, an amyloidogenic transgenic AD mouse model [B6.Cg-Tg(PDGFB-APPSwInd)20Lms/J] expressing a mutant form of human APP bearing both the Swedish (K670N/M671L) and Indiana (V717F) familial AD mutations.
|
26517904 |
2015 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
In this study, we report a 275341 G > C (Val717Leu) mutation in the APP gene in a Japanese family with early onset AD by genetic screening.
|
22702962 |
2012 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
An early-onset AD transgenic mouse model expressing the double-mutant form of human amyloid precursor protein (APP); Swedish (K670N/M671L) and Indiana (V717F), corroborated in vitro findings by showing lower levels of Aβ and amyloid plaques in the brain, when they were fed a low fat diet enriched in DHA.
|
20971855 |
2011 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
To investigate the regulatory genes responsible for the neuropathology in AD, we performed microarray analysis with APP(V717I)-CT100 transgenic mice, an animal model of AD, and isolated the S100a9 gene, which encodes an inflammation-associated calcium binding protein.
|
20098622 |
2010 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
We recently demonstrated that overexpression of ADAM10 in mice transgenic for human AbetaPP (ADAM10 x APP[V717I]) alleviated functional deficits related to Alzheimer's disease.
|
19221420 |
2009 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Further, overexpression of the SUMO E2 enzyme ubc9 along with SUMO-1 results in decreased levels of Abeta aggregates in cells transfected with the familial Alzheimer's disease-associated V642F mutant APP, indicating the potential of up-regulating activity of the cellular sumoylation machinery as an approach against Alzheimer's disease.
|
18675254 |
2008 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Levels of both APP-BP1 and Rab5 are elevated in early endosomes in cortical embryonic neurons expressing APP(V642I) or APP-BP1, in cultured skin fibroblast cells from Down syndrome subjects, and in postmortem hippocampal tissue of individuals with AD.
|
17611268 |
2007 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
In a "combined" model, expressing both tau(V337M) and the familial amyloid precursor protein AD mutation APP(V717I) in a CT100 fragment, age-dependent tau phosphorylation occurred at the same sites and was significantly augmented compared to "single" tau(V337M) mice.
|
15601849 |
2005 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
We report the effects of amyloid precursor protein (APP) fragment 714-723 (APP(714-723); peptide P1) and its V717F and V717G mutants (peptides P2 and P3, respectively) on G-protein activity ([35S]GTPgammaS binding) in membranes from postmortem human control and Alzheimer's disease (AD) brains.
|
15614786 |
2005 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Here we report on a transgenic mouse line, named Tg-APP (Sw, V717F)/B6, that expresses the human amyloid precursor protein (APP) containing the Swedish and the V717F Indiana mutations in the brains of inbred C57BL/6 mice, designed to eliminate the potential phenotypic variations attributed to the compound genetic backgrounds adopted in most AD mouse models.
|
15114629 |
2004 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
This V642I-APP knock-in mutant line may serve as a model to study the early pathogenic processes of AD in vivo and to develop therapeutics for this stage.
|
15147316 |
2004 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Transgenic mice over-expressing a mutated form of the human amyloid precursor protein (APP, 695 isoform) bearing a mutation associated with Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and wild-type controls were studied at age periods (3 and 10 months) prior to the overt development of neuritic amyloid plaques.
|
15380017 |
2004 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Here, we report that both lithium as well as valproic acid (VPA) inhibit beta-amyloid peptide (Abeta) production in HEK293 cells stably transfected with Swedish amyloid precursor protein (APP)(751) and in the brains of the PDAPP (APP(V717F)) Alzheimer's disease transgenic mouse model at clinically relevant plasma concentrations.
|
15170327 |
2004 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
The EFRH phage evoked effective auto-immune antibodies in amyloid precursor protein [V717I] (APP[V717I]) transgenic mice that recapitulate the amyloid plaques and vascular pathology of Alzheimer's disease (AD).
|
12559780 |
2003 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
To determine the effect of apoE on Abeta deposition and AD pathology, we compared APP(V717F) transgenic (TG) mice expressing mouse, human, or no apoE (apoE(-/-)).
|
10694577 |
2000 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
The PDAPP transgenic mouse overexpresses human amyloid precursor protein V717F (PDAPP minigene) and develops age-related cerebral amyloid-beta protein (Abeta) deposits similar to senile plaques in Alzheimer's disease.
|
9278541 |
1997 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.
|
8863158 |
1996 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
We conclude that this familial AD may originate from the missense mutation 717Val --> Ile in the amyloid precursor protein gene and that the clinical picture is typical of AD, except for normal-pressure hydrocephalus and psychiatric phenomena.
|
8649577 |
1996 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.
|
8795633 |
1996 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
A second member of the original family with the valine to isoleucine substitution at codon 717 of the amyloid precursor protein died after the clinical diagnosis of Alzheimer's disease had been made in life.
|
8084541 |
1994 |
rs63750264
|
|
Alzheimer's Disease
|
|
0.900 |
GeneticVariation
|
BEFREE |
We present the clinical features and limited neuropathology of AD in these families with the APP 717 Val-->Ile mutation.
|
8247223 |
1994 |